Company: The University of Texas MD Anderson Cancer Center
Location: Houston, Texas, United States
Emil J. Freireich, Professor at The University of Texas MD Anderson Cancer Center, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in hematology.
Renowned as a pioneer in medical research, Dr. Freireich continues to head efforts at The University of Texas MD Anderson Cancer Center. He joined the school in 1965, and has held a variety of roles, including chief of research in hematology, chairman of the department of hematology, and chief of the division of oncology. Some of his greatest achievements stemmed from his research into therapy for human acute leukemia and leukocyte physiology. Dr. Freireich is noted as the co-developer of combination chemotherapy and the curative therapy for childhood acute lymphoblastic leukemia, the developer of the first successful platelet replacement therapy, and the inventor of the continuous-flow cell separator. Today, he lends his knowledge to the school as a professor of medicine and the director of the Adult Leukemia Research Program.
In light of his achievements, Dr. Freireich was honored with a Pioneer in Medicine Award from the University of Illinois in 2017, a Pollin Prize from Columbia University in 2003, an Alumni Achievement Award in 2000, and an Alumnus Award from the National Institutes of Health in 1990. He also received accolades like the Outstanding Investigator Award from the National Cancer Institute at the National Institutes of Health, the Albert Lasker Medical Research Award, and the Charles F. Kettering Prize from the General Motors Cancer Research Foundation. Despite all of this, Dr. Freireich is most proud of creating innovative treatments that have saved the lives of millions of people. His professional designations include an honorary Doctor of Science, an MD, and a Bachelor of Science from the University of Illinois. Further, he is a diplomate of the American Board Internal Medicine.
For more information, please visit:
Contact Dr. Freireich: